Actinium Pharmaceuticals, Inc.
corporate_fare Company Profile
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for ATNM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Recent SEC coverage for ATNM spans 10-Q.
Recent high-impact activity:
- Actinium Q3 Loss Widens to $5.8M; Cash Falls to $28.7M With 12-Month Runway
Financial Snapshot
Short Interest & Short Volume
1.69 days to coverFINRA reported short interest of 593,218 shares in ATNM as of the October 30, 2026 settlement, a 6.0% decrease from the prior period — about 1.7 days to cover at its recent average daily volume. On November 20, 2026, 48.0% of ATNM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.